N1-((S)-1-((2S,4R)-4-hydroxy-2-(((S)-1-(4-(4-methylthiazol-5-yl)phenyl)ethyl)carbamoyl)pyrrolidin-1-yl)-3,3-dimethyl-1-oxobutan-2-yl)-N4-(11-((3-((4-methyl-2-oxo-7-(pyrimidin-2-yloxy)-2H-chromen-3-yl)methyl)phenyl)amino)-11-oxoundecyl)succinimide

ID: ALA5280121

Chembl Id: CHEMBL5280121

Max Phase: Preclinical

Molecular Formula: C59H72N8O9S

Molecular Weight: 1069.34

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ncsc1-c1ccc([C@H](C)NC(=O)[C@@H]2C[C@@H](O)CN2C(=O)[C@@H](NC(=O)CCC(=O)NCCCCCCCCCCC(=O)Nc2cccc(Cc3c(C)c4ccc(Oc5ncccn5)cc4oc3=O)c2)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C59H72N8O9S/c1-37-46-25-24-45(75-58-61-29-16-30-62-58)34-49(46)76-57(74)47(37)32-40-17-15-18-43(31-40)65-51(70)19-13-11-9-7-8-10-12-14-28-60-50(69)26-27-52(71)66-54(59(4,5)6)56(73)67-35-44(68)33-48(67)55(72)64-38(2)41-20-22-42(23-21-41)53-39(3)63-36-77-53/h15-18,20-25,29-31,34,36,38,44,48,54,68H,7-14,19,26-28,32-33,35H2,1-6H3,(H,60,69)(H,64,72)(H,65,70)(H,66,71)/t38-,44+,48-,54+/m0/s1

Standard InChI Key:  RFYHGFDYLXXYEE-NBABBAIJSA-N

Alternative Forms

  1. Parent:

    ALA5280121

    ---

Associated Targets(Human)

MAP2K2 Tclin VHL-MAP2K1/MAP2K2 (64 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 1069.34Molecular Weight (Monoisotopic): 1068.5143AlogP: #Rotatable Bonds:
Polar Surface Area: Molecular Species: HBA: HBD:
#RO5 Violations: HBA (Lipinski): HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: CX LogP: CX LogD:
Aromatic Rings: Heavy Atoms: QED Weighted: Np Likeness Score:

References

1. Wang C, Wang H, Zheng C, Li B, Liu Z, Zhang L, Yuan L, Xu P..  (2023)  Discovery of Coumarin-Based MEK1/2 PROTAC Effective in Human Cancer Cells.,  14  (1.0): [PMID:36655129] [10.1021/acsmedchemlett.2c00446]

Source